Compare BioSyntech Canada vs Remon Medical Technologies
Customers evaluate the quality of BioSyntech Canada's products using the following success metrics.
Overview
BioSyntech Canada is 30 yrs old and is based in Canada.
BioSyntech specializes in the discovery, development and manufacturing of biotherapeutic thermogels for regenerative medicine and therapeutic delivery. Its platform technology is a family of hydrogels that can be injected or applied to specific sites and which offer beneficial properties for the local repair of damaged tissue such as cartilage, bone and chronic wounds.
Remon Medical Technologies develops and commercializes smart, miniature implants which enable physicians to assess and treat a variety of medical conditions in a non-invasive manner. Remon's platform has broad applications for patient management, post-operative monitoring, nerve and tissue stimulation, local drug delivery, and drug development.
Demo Video
Leadership
Jeanne Bertonis (President)
David Frankfurter (Chief Financial Officer)
Investors
Pappas Ventures, ProQuest Investments
Boston Scientific, Brooks Keret Group
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because BioSyntech Canada has not claimed their profile.
Work for BioSyntech Canada? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for BioSyntech Canada?
Claim your profile now.
Information not available because Remon Medical Technologies has not claimed their profile.
Work for Remon Medical Technologies? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Remon Medical Technologies?
Claim your profile now.